Cytek Biosciences, Inc. (CTKB) shares outstanding

Shares outstanding · fiscal 2025
127.75M

Cytek Biosciences, Inc. (CTKB) had 127.75M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.2% lower than the 130.61M of fiscal 2024. Figures as of 18 Nov 2026, 04:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
127.75M
Change on fiscal 2024
−2.2%
Growth, 5 years
+31.4% a year
Highest on record
138.56Mfiscal 2022
Lowest on record
32.60Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Cytek Biosciences, Inc. shares outstanding, in more detail

The market data feed counts 130.78M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 31.4% a year. Across the 6 fiscal years on record (2020–2025), the highest was 138.56M in fiscal 2022 and the lowest 32.60M in fiscal 2020.

History · 6 fiscal years

Shares outstanding by fiscal year

Cytek Biosciences, Inc. shares outstanding, year by year

Cytek Biosciences, Inc. (CTKB) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025127.75M 2.2% down
2024130.61M 0.1% down
2023130.71M 5.7% down
2022138.56M 69.9% up
202181.54M 150.1% up
202032.60M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on CTKB

Cytek Biosciences, Inc., figure by figure

Cytek Biosciences, Inc. (CTKB) overview: price, valuation and scorecard

Cytek Biosciences, Inc. shares outstanding: questions and answers

How many shares does Cytek Biosciences, Inc. have?

Cytek Biosciences, Inc. (CTKB) had 127.75M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.2% lower than the 130.61M of fiscal 2024. The market data feed counts 130.78M shares outstanding today.

What is the growth rate of Cytek Biosciences, Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 31.4% a year.

What are the highest and lowest diluted share count figures on record for Cytek Biosciences, Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was 138.56M in fiscal 2022 and the lowest 32.60M in fiscal 2020.

How is Cytek Biosciences, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cytek Biosciences, Inc. (CTKB) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/CTKB/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.